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Regulation of mRNA translation is a major control point for gene
expression and is critical for life. Of central importance is the
complex between cap-bound eukaryotic initiation factor 4E
(eIF4E), eIF4G, and poly(A) tail-binding protein (PABP) that circu-
larizes mRNAs, promoting translation and stability. This complex is
often targeted to regulate overall translation rates, and also by
mRNA-specific translational repressors. However, the mechanisms
of mRNA-specific translational activation by RNA-binding proteins
remain poorly understood. Here, we address this deficit, focusing
on a herpes simplex virus-1 protein, ICP27. We reveal a direct in-
teraction with PABP that is sufficient to promote PABP recruitment
and necessary for ICP27-mediated activation. PABP binds several
translation factors but is primarily considered to activate transla-
tion initiation as part of the PABP–eIF4G–eIF4E complex that stim-
ulates the initial cap-binding step. Importantly, we find that ICP27-
PABP forms a complex with, and requires the activity of, eIF4G.
Surprisingly, ICP27–PABP–eIF4G complexes act independently of
the effects of PABP-eIF4G on cap binding to promote small ribo-
somal subunit recruitment. Moreover, we find that a cellular
mRNA-specific regulator, Deleted in Azoospermia-like (Dazl), also
employs the PABP–eIF4G interaction in a similar manner. We pro-
pose a mechanism whereby diverse RNA-binding proteins directly
recruit PABP, in a non–poly(A) tail-dependent manner, to stimulate
the small subunit recruitment step. This strategy may be particu-
larly relevant to biological conditions associated with hypoadeny-
lated mRNAs (e.g., germ cells/neurons) and/or limiting cytoplasmic
PABP (e.g., viral infection, cell stress). This mechanism adds signif-
icant insight into our knowledge of mRNA-specific translational
activation and the function of the PABP–eIF4G complex in
translation initiation.
DAZL | ICP27 | mRNA-specific translational regulation | mRNA-binding
protein | poly(A)-binding protein
Despite the importance of translational control, the mechanismsby which specific subsets of mRNAs are translationally regu-
lated are only well defined in a handful of cases. Nevertheless, it is
clear that regulation is most often mediated by factors recruited to
the 3′ untranslated region (UTR) of mRNAs and frequently occurs
at the level of initiation (1). Initiation is a multistep process in-
volving several mRNA-dependent steps, each of which requires
eukaryotic initiation factors (eIFs) (2). Initially, the m7GpppX cap is
bound by eIF4F, comprising a large scaffold protein, eIF4G, bound
to the cap-binding protein, eIF4E, and an RNA helicase, eIF4A.
The small (40S) ribosomal subunit, initiator tRNA, and associated
initiation factors are then recruited as a 43S preinitiation complex.
Recruitment is facilitated by eIF4A-dependent removal of RNA
secondary structure and by the interaction of 40S-associated
eIF3 with eIF4G. The 43S small ribosomal subunit complex then
scans the 5′ UTR to locate a start codon, recognition of which pro-
motes release of initiation factors and joining of the large (60S)
ribosomal subunit to form an 80S ribosome. Like the cap, the poly
(A) tail serves as a primary determinant of translational efficiency (3)
via the action of poly(A)-binding protein (PABP). Analysis of
mRNA-ribosomal subunit association has shown that PABP pro-
motes small subunit recruitment, an activity attributed to its ability to
stimulate cap binding by eIF4E (4). Stabilization of the cap–eIF4E
interaction requires the RNA-binding activity of their common
partner, eIF4G (5), which acts as a bridging factor mediating the
“closed-loop” mRNA conformation (1). This conformation brings
the ends of the mRNA into proximity, providing insight into how 3′
UTR-bound factors can control initiation.
Despite the rate-limiting, cap-binding step being a common
regulatory target for global and mRNA-specific regulation,
studies of diverse mRNA-specific translational repressors have
revealed that multiple initiation steps can be regulated (1).
In contrast, mechanisms are described for only a very few
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mRNA-specific translational activators, with these activators
acting at the cap-binding step. Because studies of viruses have
proved highly informative for the understanding of cellular
translational regulation, we examined the mechanism of action of
ICP27, an essential herpes simplex virus type 1 (HSV-1) protein
that is a key regulator of host and viral gene expression (6).
ICP27 regulates the translation of a subset of viral mRNAs, in-
cluding the viral mRNAs encoding VP16 and ICP5 (7, 8), via an
uncharacterized mechanism. This effect is mRNA-specific, be-
cause the translation of other studied viral and cellular mRNAs is
not ICP27-dependent (7, 8). We posited that elucidating this
mechanism may provide insight into cellular mRNA-specific reg-
ulators because HSV-1 mRNAs are, like most cellular mRNAs,
capped, polyadenylated, and translated via the canonical cap-
dependent pathway described above. HSV-1 infection is accom-
panied by posttranslational modification of some initiation factors
(9) and by relocalization of PABP to the nucleus (10, 11); how-
ever, similar modifications of the translational machinery occur in
noninfected cells, for example, as a result of cellular stress (12, 13).
Consistent with its role as an mRNA-specific translational
activator (7, 8, 14), ICP27 binds RNA, cosediments with poly-
ribosomes (14), and can be isolated with components of the
translational machinery (10, 15). Because ICP27 can stimulate
translation in the absence of other viral proteins when tethered
to the 3′ UTR of reporter mRNAs (14), its interaction with the
translational machinery must either be direct or mediated in-
directly by other cellular proteins, further supporting the idea
that it may share a mechanism of action with cellular regulators
of translation. Here, we investigate its mechanism of action,
establishing that it requires recruitment of PABP, via a direct
protein interaction, to ICP27-bound mRNAs. ICP27 activity was
also shown to depend on the integrity of eIF4G, but was sur-
prisingly found to stimulate small subunit recruitment down-
stream of the initial cap-binding event. Furthermore, we provide
evidence that this previously undescribed mechanism of mRNA-
specific translational activation also applies to at least one cel-
lular mRNA-binding protein, Deleted in Azoospermia-like
(Dazl). These results increase our knowledge of the mecha-
nisms of mRNA-specific translational activation and provide
evidence that the PABP–eIF4G interaction in metazoans has
pleiotropic effects on small ribosomal subunit recruitment.
Results
PABP Interacts with the Region of ICP27 That Stimulates Translation.
Previous studies found that ICP27 can be isolated in RNase-
sensitive complexes with multiple initiation factors (10, 15) and can
interact directly with eIF3 subunits in pull-down experiments (15),
raising the possibility that it may function by interacting with one or
more initiation factors. This possibility prompted us to screen for
such interactions by directed yeast two-hybrid (Y2H) analysis, re-
vealing a single strong interaction with PABP (Table S1). In keeping
with this finding, PABP was coimmunoprecipitated with ICP27
from HSV-1–infected cell extracts (Fig. S1 A and B), with RNase
treatment reducing coimmunoprecipitation efficiency (Figs. S1 A,
lanes 3–6 and B, lanes 3–4), presumably by eliminating mRNA-
mediated coisolation (Fig. S1C). To examine whether this associa-
tion may be functionally relevant, we initially tested whether it is
direct. Pull-down experiments with purified recombinant proteins
(Fig. S1 D and E) in the presence of RNase showed that GST-
PABP, but not GST alone, binds His-ICP27 (Fig. 1A). In the re-
ciprocal experiment, purified GST-ICP27 and His-PABP (Fig. S1 F
and G) also interact (Fig. S1H). These results establish a direct
protein–protein interaction in the absence of bridging eukaryotic
proteins or RNA (see also Figs. 1 C and E and 2 A and B).
To determine whether its interaction with PABP underlies the
ability of ICP27 to stimulate translation, ICP27 regions associated
with this activity and their interaction with PABP were probed.
Tether-function analysis (Fig. S2A) is ideally suited for delineating
functional protein regions because it permits the separation of
RNA-binding and activation domains (16). Importantly, we pre-
viously established that tethering ICP27 to the 3′ UTR of reporter
mRNAs recapitulates the robust mRNA-specific effect on trans-
lation of target mRNAs observed in infected cells (7, 14), with only
reporters to which ICP27 is tethered being translationally activated
(14). In contrast, translational stimulation of target mRNAs (e.g.,
VP16) by untethered ICP27 is inefficient outside of the context of
A
His-
ICP27
G
ST
G
ST
-
PA
B
P
 1  2  3 
In
pu
t
E
His-
PABP
In
pu
t
G
ST
G
ST
-IC
P2
7
G
ST
-1
-2
61
G
ST
-1
2-
39
7
G
ST
-1
2-
51
2
0
G
ST
-7
2-
51
2
100 14 6 66 150Intensity (%)
1 2 3 4 5 6 7
B
0
2
4
MS2
ICP27
MS2
U1A
N
or
m
ai
lis
ed
VP
16
 p
ro
te
in C
10-512
10-397
242-512
IRP PABPICP27
0
2
4
6
8
MS2-
ICP27
MS2-
139-
512
MS2-
175-
512
MS2-
201-
512
MS2
R
el
at
iv
e
St
im
ul
at
io
n
D
Fig. 1. PABP interacts directly with ICP27 regions required for translational
stimulation. (A) Immobilized purified GST-PABP or GST was incubated with
purified His-ICP27. ICP27 was detected by immunoblotting; input is 10%.
(B) Oocytes expressing ICP27 or U1A (negative control) were injected with
VP16 mRNA and luciferase mRNA as an internal control. VP16 protein levels
normalized to luciferase activity are plotted (±SEM; n = 5). (C) Y2H analysis
of PABP interactions with indicated ICP27 regions. Iron regulatory protein
(IRP) was used as a negative control. (D) Oocytes expressing MS2, MS2-ICP27,
or MS2-ICP27 truncations (Fig. S3A) were coinjected with m7G-Luc-MS23 and
β-gal mRNAs (Fig. S2A, [1] and [7]). Effects on translation were measured by
luciferase assay normalized to β-gal activity. Translational stimulation rela-
tive to MS2 protein alone (=1) is plotted (±SEM; n = 3). (E) Immobilized
purified GST or GST fusions of ICP27 or indicated truncations (Fig. S3A and
Table S2) were incubated with purified His-PABP. PABP was detected by
quantitative immunoblotting, and band intensities are shown, with the
band intensity of lane 3 set to 100%. Input is 150%.
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Fig. 2. Translationally active ICP27 interacts with two domains of PABP and
recruits PABP to mRNA. (A) Y2H analysis of ICP27 interactions with PABP
domains. IRP was used as a negative control. (B) Immobilized purified GST or
GST fusions of PABP or indicated truncations (Table S2) were incubated with
HSV-1–infected cell extracts in the presence of RNase 1. ICP27 was detected
by immunoblotting. (C) Y2H analysis of the PABP C-terminus (Ct, amino acids
396–633), RRM1-2Rd with ICP27 (amino acids 10–512), or ICP27 containing
the M15 or M16 mutation. IRP and MS2 were used as negative controls.
(D) Oocytes expressing MS2 or MS2-ICP27 were injected with ApG-Luc-MS23
(L) or ApG-Luc-ΔMS2 (LΔ) (Fig. S2A, [2] and [6]). PABP was immunoprecipi-
tated (P) from lysates [control: nonspecific rabbit IgG (c)] and detected by
immunoblotting (input is 27%). The presence of copurified luciferase or
endogenous β-actin mRNAs was assessed by RT-PCR.
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infection (Fig. 1B and Fig. S2 B and C), suggesting that an un-
identified ancillary viral factor, which can be substituted by tethering,
may normally aid its RNA-binding specificity. Tethering studies
were performed in Xenopus laevis oocytes, which offer a unique
opportunity to analyze multifunctional regulators (16) because re-
porter mRNAs can be directly microinjected into the cytoplasm,
permitting effects on translation to be studied independent of ICP27
roles in regulating mRNA transcription, processing, and nuclear ex-
port (17). Furthermore, mRNAs remain remarkably stable in oocytes
even without a functional cap or poly(A) tail (Fig. S2D) (18), pro-
viding an opportunity for detailed mechanistic analysis in intact cells.
Previous analysis also revealed that the C-terminal 105 amino acids of
ICP27 are essential to stimulate translation (14), suggesting that
factors required for this activity interact with this region. Importantly,
in this regard, Y2H analysis shows that the PABP-binding site lies
within the C-terminal 115 amino acids (Fig. 1C, compare amino acids
10–512 and amino acids 10–397 and Fig. S3A). By contrast, we find
that the N-terminal region is dispensable both for translational stim-
ulation (Fig. 1D, MS2-139–152, MS2-175–512, and MS2-201–512
and Fig. S3A) and PABP binding (Fig. 1C, amino acids 242–512).
Because the N-terminal region contains the RNA-binding domain
(RGG-box), this result lends weight to the RNA independence of the
ICP27–PABP interaction. Similar results were obtained by GST pull-
down of purified PABP with ICP27 domains in the presence of
RNase 1 (Fig. 1E, Fig. S3B, and Table S2). Taken together, these
results show that PABP interacts with the region of ICP27 re-
sponsible for its ability to promote translation.
Translationally Inactive Mutants of ICP27 Fail to Interact with PABP.
PABP1 comprises several functional domains known to mediate
RNA and/or protein interactions (19) (Fig. S3C). Y2H analysis
revealed that ICP27 interacts strongly with the RNA-recognition
motifs (RRMs) 1–2 (residues 3–182) as well as with the C-terminal
region (residues 395–633) of PABP1 (Fig. 2A). Dual binding sites
have been described for several other PABP partner proteins
(20). Because both ICP27 and PABP are RNA-binding pro-
teins, RRM1-2Rd (Y56V, F142V) (16), an RNA-binding–
deficient mutant of RRM1-2, was used to confirm further that
their interaction is not RNA-mediated (Fig. 2A). The C terminus
of PABP does not bind RNA (19). To verify these results,
PABP1 domains were purified as GST fusions (Fig. S3D and
Table S2) and used in pull-down assays in the presence of RNase 1.
Fig. 2B shows that although no single RRM (lanes 4–7) interacts
with ICP27, RRM1-2 (lane 8) and the C-terminal region (lane 14)
interact, confirming our Y2H mapping. RRM2-3 (lane 9) also
shows significant interaction with ICP27, whereas RRM3-4 (lane
10) interacts only weakly, indicating that ICP27 has strong affinity
for a region within the N-terminal 190 amino acids of PABP1. The
PABP1 C-terminal domain is composed of a proline-rich linker
and the PABC domain (Fig. S3C), and further mapping showed
that ICP27 interacts with the N-terminal portion of the linker
region (present in C1 and C5 but not in C2; Fig. 2B, lanes 11–14).
Interestingly, several C-terminal amino acid substitutions [M15
(P465L, G466E) or M16 (C488L)] (21) abrogate the ability of
ICP27 to associate with polyribosomes in infected cells and to
stimulate translation when tethered (14), providing a tool with
which to probe further the importance of PABP binding. Fol-
lowing delineation of the ICP27-binding sites in PABP, the in-
teraction of the translationally inactive ICP27 mutants (M15 and
M16) with these binding sites was examined by Y2H analysis and
immunoprecipitation from cells infected with M15/M16 mutant
virus. Critically, both point mutants failed to interact with PABP1
(Fig. 2C and Fig. S3E), directly linking ICP27 activity and PABP
binding, leading us to conclude that this interaction is crucial for
ICP27-mediated translational stimulation.
ICP27 Recruits PABP to mRNA. The dependence of ICP27 activity on
PABP binding raised the hypothesis that ICP27 may function to
promote PABP recruitment to specific mRNAs. To test this hy-
pothesis, RNA coimmunoprecipitations of tethered unadenylated
reporter mRNAs were performed using antibodies against PABP
(Fig. 2D). Critically, PABP fails to associate with these mRNAs
unless they contain MS2-binding sites (Fig. 2D, lanes 11 and 13)
and unless MS2-ICP27, rather than MS2 alone (lanes 7 and 11), is
present. Endogenous polyadenylated β-actin mRNA, which binds
PABP directly via its poly(A) tail, was a positive control. Thus,
MS2-ICP27 is sufficient to bridge the association of PABP with
the reporter mRNA, providing strong direct support for a mech-
anism by which ICP27 functions to enhance the recruitment of
PABP to mRNA. In keeping with this finding, manipulating poly
(A) tail status, and thus poly(A)-mediated recruitment of PABP to
the reporter mRNAs, alters the relative magnitude of stimulation
by tethered ICP27 (Fig. S4 A and B).
ICP27 Stimulates Initiation of Translation Independently of the
Cap-Binding Event. In metazoan cells, PABP drives small ribo-
somal subunit recruitment, a function attributed to enhancement of
cap binding by eIF4E, as part of the PABP–eIF4G–eIF4E complex
(2, 4). Therefore, our results raise the possibility that ICP27, like
other mechanistically defined mRNA-specific activators, may exert
its effect at the initial cap-binding step (22, 23). To address this
possibility, the ability of MS2-ICP27 to stimulate a reporter mRNA
bearing a nonfunctional ApppG-cap structure (Fig. S2A, [2]) was
tested. ApppG-capped mRNAs are stable (Fig. S2D), although
translated at low efficiency (Fig. S5A), because they are not rec-
ognized by eIF4E. Surprisingly, ICP27 activates the translation of
this reporter mRNA to a similar extent as the m7GpppG-capped
reporter (Fig. S5B). Thus, the 5′ cap-recognition event appears
dispensable for translational activation by tethered ICP27, sug-
gesting that it activates via an undescribed mechanism. Because the
inherent instability of purified ICP27 confounds cell-free system
analysis of initiation intermediates (e.g., by sucrose gradients), we
used reporters with different viral internal ribosome entry sites
(IRESs) to further delineate its mechanism of action in intact cells.
Critically, these IRESs have distinct, well defined, noncanonical
mechanisms to recruit small ribosomal subunits and are functional
in X. laevis oocytes (24) (Fig. S5A). Hepatitis A virus (HAV) RNA,
like many other IRES-driven viral RNAs, lacks a physiological cap
and does not require the cap–eIF4E interaction for its translation,
although it may use eIF4E noncanonically (25, 26). Importantly,
HAV IRES-mediated initiation is stimulated by ICP27 (Fig. 3A and
Fig. S2D), verifying that cap recognition is not required for MS2-
ICP27 action. The eIF4E independence of ICP27 was probed fur-
ther using a poliovirus (PV) IRES-dependent reporter mRNA
because eIF4E is dispensable for PV translation (27). PV-IRES
translation is stimulated to levels comparable to the m7GpppG-
capped reporter (Fig. 3B and Fig. S2D), establishing that neither
the cap nor the cap-binding protein is required for ICP27-mediated
activation. These findings suggest that the ICP27–PABP complex
acts downstream of cap binding to stimulate ribosomal subunit re-
cruitment. To test this possibility, a reporter mRNA containing the
classical swine fever virus (CSFV) IRES was used. Small subunit
recruitment by the CSFV IRES differs significantly from both ca-
nonical initiation (28) and small subunit recruitment at HAV and
PV IRESs (25) in that it is independent of all eIF4 factors and eIF3
(28, 29). Crucially, the ability of ICP27 to stimulate translation was
completely abrogated on CSFV IRES-driven reporter mRNAs
(Fig. 3C and Fig. S2D). This result contrasts with the ability of some
translational repressors that target 60S joining to regulate translation
of such mRNAs (30). Thus, taken together, these results establish
that the ICP27–PABP complex acts during initiation but downstream
of cap binding to enhance small subunit recruitment through one or
more of the initiation factors required by PV but not CFSV (i.e.,
eIF4G, eIF4A, eIF4B, eIF3). Because this finding was unexpected,
we directly tethered PABP, recapitulating the reporter mRNA
translational stimulation by ICP27 (Fig. S5C), consistent with PABP
mediating the effects of ICP27 and being able to activate small sub-
unit recruitment independently of its ascribed effects on cap binding.
Downstream Effectors of the ICP27–PABP Interaction. Because
ICP27, surprisingly, does not enhance small subunit recruitment
via a PABP-eIF4G-eIF4E–mediated effect on cap binding, we
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investigated which PABP partner(s) transduce(s) its effects. PABP
interacts with several initiation factors through different domains (Fig.
S3C); thus, we tested which of these domains is sufficient to re-
capitulate the effect of ICP27 when directly tethered to our reporter
mRNA panel. Interestingly, RRM1-2 (Fig. 3D) efficiently stimulated
the translation of m7GpppG-capped (set to 100%), ApppG-capped,
and HAV-IRES and PV-IRES reporters, but not the translation of a
CSFV IRES reporter, reproducing the effects of MS2-ICP27 and
MS2-PABP. This result indicates that eIF4G and/or Paip1, a trans-
lation factor with homology to eIF4G, both of which bind RRM1-2
(Fig. S3C), may serve as a downstream effector of ICP27 activity.
PABP Forms a Complex with ICP27 and eIF4G.Because we have shown
that ICP27 does not interact directly with eIF4G or Paip1 (Table
S1) (15), a role for these factors would require that ICP27 and
eIF4G or Paip1 interacts with PABP simultaneously. Because an
interaction of ICP27 with RRM1-2 could disrupt eIF4G or
Paip1 binding, we tested whether their binding sites are separable.
Fig. 4A shows that ICP27 binds a region of RRM1-2 that binds
Paip1 but not eIF4G (RRM1-2Nt) (16) suggesting that ICP27 and
eIF4G may be able to interact simultaneously with PABP. To
probe directly whether PABP can bridge ICP27 and eIF4G, GST
pull-downs with purified recombinant proteins (Figs. S1 F and G
and S6A) were performed. These pull-downs confirmed that
eIF4G and ICP27 do not detectably interact directly and revealed
that eIF4G associates with GST-ICP27 only in the presence of
PABP, consistent with the formation of an ICP27–PABP–eIF4G
complex (Fig. 4B).
Stimulation of Translation by ICP27-PABP Requires eIF4G. Cap binding
is enhanced by eIF4G, but eIF4G also has a direct role in small
subunit recruitment. Thus, to ascertain whether it is functionally
targeted in ICP27-mediated translational activation, modified
tether-function assays were undertaken in which mRNAs encod-
ing picornavirus 2A protease (2Apro) or U1A (negative control)
were coinjected with reporter mRNAs. Cleavage by 2Apro sepa-
rates an N-terminal part of eIF4G that binds eIF4E and PABP
from the C-terminal part that binds RNA, eIF4A, and 40S
subunit-associated eIF3 (20). A lacZ mRNA containing the
eIF4G-independent, 2Apro-insensitive CSFV IRES served as a
critical internal control (Figs. S2A, [8] and S6B). X. laevis eIF4G,
but not Paip1 or PABP, is efficiently cleaved by 2Apro (Fig. S6C),
allowing us to test specifically the requirement for eIF4G in
ICP27-mediated translational stimulation. ICP27 contains no
predicted 2Apro cleavage sites (www.cbs.dtu.dk/services/NetPicoRNA/).
Critically, stimulation by tethered PABP and ICP27 is reproducibly
decreased in the presence of 2Apro (Fig. 4C). By contrast, 2Apro
does not alter translational stimulation by tethered stem-loop–
binding protein (SLBP) (Fig. 4C), a translational activator that
acts independently of the PABP–eIF4G interaction (23, 24). This
result establishes eIF4G as the PABP partner required to mediate
the cap-independent effects of ICP27 on translation initiation.
Thus, our results support a model for mRNA-specific activation in
which formation of an alternative closed-loop complex comprising
a 3′ UTR-bound mRNA-specific activator, PABP, and eIF4G
stimulates the small ribosomal subunit recruitment step directly,
downstream of the ascribed effects of the PABP–eIF4G complex
in promoting cap binding (Fig. 5A, step 2).
A Cellular Activator Shares this Mechanism. Our results raise the
possibility that other viral or cellular proteins might use this PABP-
dependent, cap-independent mechanism. Of particular interest were
observations pertaining to Dazl, a 3′ UTR-bound regulator essential
for germ cells. Germ cells often store mRNAs with short poly(A)
tails; Dazl can stimulate the initiation of nonadenylated mRNAs at
an undefined step but requires PABP interaction for this activity
(31). Because these shared properties suggest it may use the
mechanism defined for ICP27, we compared its mode of action with
the mode of action of ICP27. Importantly, we find that Dazl-
mediated activation is also 2A-protease–sensitive (Fig. 5B) [Dazl
contains no predicted 2Apro cleavage sites (www.cbs.dtu.dk/services/
NetPicoRNA/)] and that Dazl recapitulates the pattern of stimula-
tion of the panel of reporter mRNAs observed with ICP27 (Fig. 5 C
and D and Fig. S6D), revealing that this PABP-interacting trans-
lational activator shares with ICP27 the ability to activate translation
in an eIF4G-dependent manner downstream of cap binding. These
results strongly imply that the elucidated ICP27 mechanism is rele-
vant to regulation of translation by cellular RNA-binding proteins.
Discussion
By exploring the function of ICP27, we have uncovered a mechanism
for mRNA-specific activation that cannot be explained in terms of
existing models that describe enhancement of the rate-limiting
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cap-binding event. Rather, we find that ICP27 and Dazl recruit
PABP, which can exert an effect downstream of this initial cap-
binding event, and is therefore not dependent on eIF4E (Fig. 5A,
step 1) but nonetheless uses the PABP-partner protein eIF4G to
promote small subunit recruitment. This analysis informs both on
mechanisms of mRNA-specific translational activation and, more
broadly, on the function of the PABP–eIF4G complex in initiation.
Our data confirm reports that PABP coimmunoprecipitates with
ICP27 (10, 15) (Fig. S1) and extend those reports by showing that
the RNase-insensitive fraction reflects a direct ICP27–PABP in-
teraction (Fig. 1 and Fig. S1), because both RNase-treated purified
proteins and domains/mutants of PABP and ICP27 that do not bind
RNA interact. In contrast, ICP27 fails to interact detectably with
other tested translation factors (Table S1). We demonstrate the
function of this interaction: ICP27 recruits PABP to mRNAs, and its
abilities to bind PABP and to activate translation are linked (Fig. 2)
(14), with the latter also requiring eIF4G (Fig. 4). ICP27-PABP-
eIF4G–dependent activation of initiation (Figs. 3–5A) is consistent
with the disassociation of VP16 mRNA from polysomes during
infection with ICP27-deficient viruses (7); with coisolation of
ICP27 with PABP, eIF4G, and eIF3 from infected cells (15); and
with the dependence of translational activation of both natural
target mRNAs (8) and tethered reporter mRNAs (14) on the
PABP-interacting C terminus of ICP27 (8, 14) (Fig. 1), as well as
with point mutations therein that abrogate PABP binding disrupt-
ing translation of reporter mRNAs and polysome association in
infected cells (14). Our observations that the magnitude of ICP27-
mediated stimulation is poly(A)-tail–sensitive (Fig. S4) and that
tethered PABP can functionally substitute for ICP27 in stimulating
mechanistically distinct reporter mRNAs (Fig. S5C) provide further
support for the role of PABP. Our proposed model of translational
stimulation by ICP27-PABP-eIF4G downstream of cap binding is
supported by the following data: Tethering the eIF4G-binding do-
main of PABP to reporter mRNAs with different mechanisms of
small subunit joining recapitulates the effects of ICP27 (Fig. 3),
eIF4G can form a complex with ICP27 and PABP, and proteolytic
cleavage of eIF4G abrogates translational stimulation (Fig. 4).
Previous analysis using PABP-depleted extracts to examine mRNA
and ribosome subunit association established that PABP pre-
dominantly promotes small subunit recruitment, a function ascribed
to its ability to promote eIF4E cap binding in a manner that is
dependent on RNA binding by eIF4G (4, 5). However, our results
firmly establish that the cap, eIF4E (Fig. 3), and the poly(A) tail
(14) (Figs. 1, 3, and 5) are dispensable for ICP27/Dazl function,
indicating that the effects on small subunit recruitment revealed by
comparison of HAV/PV and CSFV IRESs (Fig. 3) are independent
of enhanced cap or poly(A) binding. Rather, our results are most
consistent with PABP-eIF4G effects on initiation not acting exclu-
sively via cap binding by eIF4E, but more broadly to promote
eIF4G function: enhancing its direct role in small subunit re-
cruitment (Fig. 5A, step 2), namely, delivery of eIF4A, which creates
an unstructured subunit-binding site, and its interaction with eIF3,
which facilitates small subunit recruitment (2). This mechanism is
consistent with the coisolation of ICP27 with PABP, eIF4G, and
eIF3 (15) in infected cells and with the eIF4G, eIF4A, and
eIF3 independence of CSFV IRES-driven 40S recruitment (28),
in contrast to recruitment mediated by the HAV or PV IRESs (25,
27, 32). It is also consistent with the idea that PABP may enhance
RNA binding by eIF4G (5), which would be expected to increase the
efficiency of all eIF4G-dependent steps and not selectively those steps
mediated via eIF4E. Thus, although our analysis has allowed the ef-
fects of the PABP–eIF4G complex on downstream events to be rec-
ognized, informing on both mRNA-specific activation and the role of
the PABP–eIF4G complex during initiation, it does not exclude that
ICP27/Dazl–PABP–eIF4G complexes can also enhance cap binding.
Our work highlights a way in which viruses target PABP function
to hijack the host translational machinery (20). However, because
HSV-1 mRNAs are capped and polyadenylated (9), the question is
raised of why their translation should require an additional means
of PABP recruitment. Although translation is not shut down during
HSV-1 infection, it is partially impeded [in addition to widespread
destruction of mRNAs (9)], necessitating the involvement of virus-
encoded proteins to augment initiation efficiency, as exemplified by
ICP6-mediated stimulation of otherwise suboptimal eIF4F assembly
(6). Thus, ICP27 may function in this capacity by targeting small
subunit recruitment via PABP-eIF4G to promote the translation of
specific viral mRNAs, two of which (VP16 and ICP5) have been
identified to date. Intriguingly, PABP is relocalized to the nucleus in
an ICP27-independent manner at late times postinfection (10, 11),
suggesting that ICP27 may provide a means to direct limiting
amounts of cytoplasmic PABP to a subset of viral mRNAs late in
infection (7, 8). Moreover, because PABP nuclear export is largely
mRNA-driven in mammalian cells (12), and ICP27 promotes ex-
port of viral mRNAs (17), it is possible that the ICP27–PABP in-
teraction may allow nuclear-retained PABP to be recruited and
exported on these mRNAs, enabling their efficient translation.
Specific binding of ICP27 to mRNAs that it translationally activates
may be aided by another viral factor (Fig. 1B).
In being able to activate initiation downstream of cap binding,
ICP27 differs from other mechanistically defined mRNA-specific
translational activators. Serine arginine splicing factor 1 (SRSF1/
SF2/ASF) promotes initiation by releasing eIF4E from 4E-BP
sequestration, permitting eIF4E-eIF4G binding (22). SLBP and
rotavirus nonstructural protein 3 (NSP3) bind unadenylated
mRNAs, forming end-to-end complexes with eIF4E and eIF4G,
but not with PABP (23, 33). In contrast to ICP27, SLBP fails to
activate cap-independent translation (24) and NSP3-mediated
activation is enhanced by the 5′ cap (33).
Our results reveal that the PABP–eIF4G interaction is a target
not only for global and mRNA-specific repression (34) but also for
mRNA-specific activation, highlighting the regulatory importance
of this complex. Our analysis of Dazl, which activates the translation
of hypoadenylated germ-cell mRNAs (31), shows that this PABP-
eIF4G–dependent effect on 43S joining can be extended to at least
one cellular mRNA-specific translational activator (Fig. 5). Because
Dazl and ICP27 share no sequence homology, this finding indicates
that different motifs can recruit PABP to mediate translational
activation, suggesting that this mechanism may be used by a wide
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Fig. 5. (A) Model for ICP27-mediated translational stimulation of HSV-1 mRNA.
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variety of proteins. However, the function of PABP-recruiting pro-
teins may also be affected by other partners, and recruited PABP
would need to maintain its interactions with initiation factors to
mediate activation. Interestingly, during the course of this study, a
new cellular 3′ UTR-bound mRNA-specific activator, DAZAP1, was
identified and found to be able to stimulate translation independently
of the cap (35). Although a mechanism has not been determined for
DAZAP1 function, its ability to stimulate translation does not appear
to involve a direct interaction with eIF4G (35); thus, it is tempting to
speculate that DAZAP1 may use PABP or another factor to mediate
binding to eIF4G to promote events downstream of cap binding. This
concept is reminiscent of the “variations on a theme” observed for
3′ UTR-bound repressors that directly (e.g., Bicoid) or indirectly (e.g.,
Bruno) contact eIF4E or its homologs to block association with
eIF4G (1).
In summary, our results indicate that mRNA-specific activators can
regulate small subunit joining through PABP–eIF4G interaction by a
means other than via enhanced cap binding. Such a “cap- and poly
(A) tail-independent” and PABP- and eIF4G-dependent mechanism
would permit the translation of specific mRNAs under a variety of
biological conditions: translational activation of hypoadenylated
mRNAs (e.g., in germ cells or neurons), maintaining translation
during viral infection or cell stress when PABP becomes pre-
dominantly nuclear, or conceivably when cap-dependent trans-
lation is repressed by 4E-binding proteins. Detailed analysis of
other mRNA-specific regulators will reveal the extent to which
this mechanism forms a paradigm for the action of other PABP-
binding activators.
Materials and Methods
Plasmids, Cells, Viruses, and Antibodies. Detailed information on plasmids,
cells, viruses, and antibodies is provided in SI Materials and Methods.
Tether-Function Assay. Tether-function assays were performed as described
(16) except for experiments with 2A protease, as described in SI Materials
and Methods.
Protein Expression and Purification. GST, GST-fusion proteins, His-ICP27, and
His-PABP1 were expressed in Escherichia coli BL21 (DE3) pLysS (Novagen).
Details of purifications are provided in SI Materials and Methods.
Protein Interaction Assays. Details of GST pull-downs, (RNA) coimmunopre-
cipitation, and Y2H assays are provided in SI Materials and Methods.
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SI Materials and Methods
Plasmids.
Tether-function MS2-fusion plasmids. MS2-fusion plasmids pMSPN
(expressing MS2 coat protein), pMS2-U1A, pMS2-PAB (PABP1),
pMS2 1-2 (PABP1 RRM1-2) (16), and pMS2-mDazl (31), as well as
the construct encoding the MS2-xSLBP fusion protein (24), were
described previously. pMSPN27 (expressing MS2-ICP27) was con-
structed as follows. The ICP27ORFwas amplified using PCRprimers
5′-AAACT CGAGA TGGCG ACTGA CATTG ATATG CTAAT
TG and 5′-CCTCG GATCC CTAAA ACAGG GAGTT GCAAT
AAAAA TATTT GCC. The PCR product was inserted into the
XhoI/BamHI sites of pMSPN. pMSPN-M15 and pMSPN-M16 were
created by PCR amplification of the 3′ 302 bp of the mutant
M15 and M16 ORFs from viral DNA using primers 5′-ATATA
CACAG TGTGT TCGCG GCGGC GTC and 5′-CCTCG
GATCC CTAAA ACAGG GAGTT GCAAT AAAAA TATTT
GCC. The NsiI-BamHI fragment of pMSPN27 was exchanged with
the corresponding PCR products. pMSPN-d0-4 (expressing MS2
fused to ICP27 amino acids 139–512) was made by exchanging a
DraIII-NsiI fragment containing the d3-4 deletion (amino acids 109–
138) from pMd3-4 (ref. 21 and references therein) with the corre-
sponding fragment in pMSPN27, cutting with XhoI (removing the
sequence encoding amino acids 1–138), and religating. pMSPN-d0-6
(expressing MS2 fused to ICP27 amino acids 175–512) was made by
exchanging a DraIII-NsiI fragment containing the d5-6 deletion
(amino acids 153–174) from pCITE-d5-6 (36) with the corresponding
fragment in pMSPN27, cutting with XhoI (removing the sequence
encoding amino acids 1–174), and religating. pMSPN-d0-7 (express-
ing MS2 fused to ICP27 amino acids 201–512) was made by ex-
changing a DraIII-NsiI fragment containing the d6-7 deletion (amino
acids 174–200) from pM27-d6-7, a pM27 (ref. 21 and references
therein) mutant containing this deletion, with the corresponding
fragment in pMSPN27, cutting with XhoI (removing the sequence
encoding amino acids 1–200), and religating. pMd3-4, pCITE-d5-6,
and pM27-d6-7 were kindly provided by Stephen Rice (University of
Minnesota, Minneapolis, MN).
Tether-function reporter constructs. pLG-MS2 (expressing Luc-MS23),
pLGENB1 (expressing Luc-ΔMS2) (16), pLuc-MS2-pA (expressing
Luc-MS23-pA), pJK350 (expressing the β-gal internal control
mRNA) (31), PV-IRES-Luciferase-MS23, and CSFV-IRES-Lucif-
erase-MS23 reporter constructs (24) were previously described.
pHAV-Luc (expressing HAV-IRES-Luc-MS23) was constructed as
follows. The sequence encoding the HAV IRES and N-terminal
48 amino acids of the HAV capsid protein (GenBank accession
no. M14707.1; nucleotides 48–884) was amplified using primers
5′-TTTTA AGCTT GGTGA GGGGA CTTGA TACC and
5′-CCCCA AGCTT TGATC CACAGAAGTA AAATA AG. The
resulting fragment was inserted in-frame with the luciferase gene
into the unique HindIII site of pLG-MS2. pCSFV-lacZ expressing
the CSFV-IRES-lacZ internal control was constructed as follows.
The sequence containing the CSFV IRES and encoding the
N-terminal 23 amino acids of the CSFV polyprotein was amplified
from pCSFV-CAT (24) with primers 5′-CAGTC AGGAT CCGTC
GACAA GGTTA GCTC and 5′-CAGTC AGGAT CCGGT
TCCTC CACTC CCACT GGT. The PCR product was inserted in-
frame with the lacZ gene into the unique BamHI site of pJK350.
pCSFV-CAT was kindly provided by Matthias Hentze (European
Molecular Biology Laboratory, Heidelberg, Germany).
Plasmids used for the 2A protease assay. pGEM-hU1A was previously
described (16). Swine vesicular disease virus 2A protease was
expressed from pGEM3Z/J1 (37), a gift from Graham Belsham
(Technical University of Denmark, Kongens Lyngby, Denmark).
VP16 expression plasmid.The sequence corresponding to the complete
VP16 mRNA, including the 5′ UTR and 3′ UTR, was amplified
with primers 5′-TTTTC TAGAG TCATT CCTCG GGAAC
GGACG and 5′-TTTGC TCAGC GGTTT TGTAA TGTAT
GTGCT CGTG from DNA purified from BHK cells infected
with HSV-1 strain 17 (National Center for Biotechnology In-
formation accession no. NC_001806.2) using DNAzol (Invitrogen).
The resulting product was inserted into the XbaI and BlpI sites of
pET52b(+) (Novagen), yielding pET-VP16.
Y2H plasmids. Fusions of ICP27 truncations to the GAL4 DNA-
binding domain (DNA-BD) [p502CBD (amino acids 10–512),
p270CBD (amino acids 242–512), and pN397BD (amino acids 10–
379)] were previously described (38). The same truncations were
fused to the GAL4-activation domain using the unique BamHI and
EcoRI sites of pACT2 (Clontech) to create p502CAD, p270CAD,
and pN397AD. Fusions of M15 and M16 mutants (amino acids 10–
512) to the GAL4 DNA-BD and DNA activation domains were
made by exchanging DraIII-BsiWI ICP27 fragments containing the
M15 or M16 mutations from pMSPN-M15 and pMSPN-M16, re-
spectively, with the corresponding wild-type fragments in 502CBD
(creating pM15-CBD and pM16-CBD) and 502CAD (creating
pM15-CAD and pM16-CAD). PABP1 truncation plasmids used in
the Y2H assay (PAB1-2, PAB3-4, PAB-Ct, PAB1-2Nt, and PAB-
Rd), pACT-IRP, pACT-4GNt, pACT-Paip1, and LexA-MS2 were
previously described (16).
Protein expression plasmids.GST-ICP27 was expressed from pGEX-27
(36), kindly supplied by Stephen Rice (University of Minnesota,
Minneapolis, MN). pGST-1–261 was made by inserting a 0.8-kb
BamHI-SalI fragment from pGEX-27 (encoding ICP27 amino acids
1–261) into the BamHI and SalI sites of pGEX-5X-3 (Amersham
Bioscience) in-frame with the GST coding sequence. pGST-12–
397 was made by inserting a 1.2-kb EcoRI-BamHI fragment from
pN397BD (encoding ICP27 amino acids 12–397) into the EcoRI
and NotI sites of pGEX-5X-1 (Amersham Bioscience) using a
BamHI-NotI adaptor. pGST-12–512 was made by inserting a 1.5-kb
EcoRI-BamHI fragment from p502CBD (encoding ICP27 amino
acids 12–512) (38) into the EcoRI and NotI sites of pGEX-5X-1
(Amersham Bioscience) using a BamHI-NotI adaptor. pGST27-72–
512 was made by inserting a 1.3-kb EcoRI-BamHI fragment from
p440CBD (encoding ICP27 amino acids 72–512) (38) into the
EcoRI and NotI sites of pGEX-5X-1 using a BamHI-NotI adaptor.
His-ICP27 was expressed from pET63, which contains the ICP27
ORF cloned into the SacI and BamHI sites downstream of the
T7 promoter in pET28c (Novagen). His-PABP1 was expressed
from pET-hPABP1 (35). GST-PABP1 was expressed from pGEX-
2T-PABP1 (39), kindly provided by Amelia Nieto (Consejo Supe-
rior de Investigaciones Cientificas, Madrid, Spain). Plasmids
expressing GST fusions of PABP1 domains were described pre-
viously [pGEX6P-PABP1-RRM1-HA, pGEX6P-PABP1-RRM2-
HA, pGEX6P-PABP1-RRM3-HA, pGEX6P-PABP1-RRM4-HA,
pGEX6P-PABP1-RRM1+2-HA, pGEX6P-PABP1-RRM2+3-HA,
pGEX6P-PABP1-RRM3+4-HA, pGEX6P-PABP1-C1-HA, and
pGEX6P-PABP1-C2-HA (40)], which were kind gifts from Nahum
Sonenberg, (McGill University, Montreal, QC, Canada), as well as
pPABP1-C5 (41), kindly provided by Jürgen Brosius (University of
Münster, Muenster, Germany). The pGST–PABP1–C-terminal do-
main contains a fragment of human PABP1 cDNA encoding the C-
terminal region (amino acids 388–636). This region was PCR-amplified
with primers 5′-GAGCG GATCC CAAGT GTACG AGCTG TTC
and 5′-GCGCG AATTC TTAAA CAGTT GGAAC ACCGG.
The product was inserted into the BamHI and EcoRI sites of
pGEX-5X-3.
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Cells and Viruses. BHK C13 cells, wild-type HSV-1, ICP27-mutant
strains carrying the M15 and M16 point mutations, and the
ICP27-deficient mutant 27lacZ were grown as described else-
where (21, 38).
Antibodies. Primary antibodies were as follows: ICP27 1113 and
1119 (Virusys; diluted 10−4), PABP1 monoclonal 10E10 (Abcam;
diluted 10−4), PABP1 polyclonals (Covalab; diluted 2 × 10−4),
GAPDH (no. H86504M, AMS Biotechnology; diluted 10−3),
GST (no. 27-4577-01, Amersham; diluted 10−4), polyhistidine
(Sigma; diluted 10−3), eIF4G and Paip1 (kindly provided by
S. Morley, University of Sussex, Brighton, UK; diluted 10−4 and
2 × 10−4, respectively), VP16 ab4808 (Abcam; diluted 3 × 10−4),
and ePABP (diluted 10−3) (31). Secondary antibodies were
horseradish peroxidase-conjugated anti-rabbit (Sigma; diluted
10−5), anti-mouse (Pierce; diluted 10−4), or anti-goat (Sigma;
diluted 10−3) IgG for detection by enhanced chemiluminescence
(GE Healthcare) and Alexa Fluor 680 goat anti-rabbit or anti-
mouse (Invitrogen; diluted 10−4) for quantitative analysis using
an Odyssey Infrared Imager (LI-COR Biosciences).
Translational Stimulation of VP16 mRNA. Xenopus laevis oocytes
were injected with 50 ng of mRNAs (transcribed in vitro from
pET63 and pGEM-hU1A) expressing ICP27 or U1A (negative
control). After allowing protein expression, the oocytes were
injected with VP16 mRNA (50, 250, or 500 pg; transcribed
in vitro from pET-VP16), along with a luciferase reporter
mRNA (Fig. S2A, [1]) as an internal control to adjust for dif-
ferences in mRNA injection efficiency, and incubated overnight.
VP16 protein was assayed by quantitative immunoblotting and
normalized to luciferase activity levels.
Modified Tether-Function Assay with 2A Protease. In these assays,
the reporter mRNA mix (50 nL per oocyte) contained 20 ng/μL
m7GpppG-Luc-MS2 mRNA and 70 ng/μL ApppG-capped,
unadenylated CSFV-lacZ mRNA alongside 0.4 μg/μL m7GpppG-
capped U1A mRNA or 2A protease mRNA. Oocytes were in-
cubated for a further 3 h before assay. Data are from a minimum of
three independent experiments, with the translation level of
MS2 alone set to 1. Error bars indicate SEM. Statistical analysis
was performed with a two-tailed unpaired Student’s t test. P ≤
0.05 was considered significant.
RNA Stability Analysis. Total RNA was extracted from injected
oocytes (same method as used for tether-function assay) using Tri
Reagent (Sigma), and first-strand cDNA was synthesized from
total RNA with an AMV Reverse Transcriptase Kit (Roche)
according to the manufacturer’s instructions. Quantitative RT-
PCR analysis was performed with an ABI 7500 Fast Real-Time
PCR System (ABI) by SYBR I green incorporation with lucif-
erase primers 5′-GGCGC GGTCG GTAAA GTT and 5′-
AGCGT TTTCC CGGTA TCCA. Data analysis was performed
with AB17500 software. Mean threshold cycle (Ct) values were
plotted with error bars representing SEM.
Gel Electrophoresis and Immunoblotting. Denatured protein samples
were resolved on 10% SDS/PAGE or 4–12% Bis-Tris gradient gels
(Invitrogen) and transferred to Immobilon-P or Immobilon-FL
membranes (Millipore) for detection by enhanced chemiluminescence
(GE Healthcare) or for quantitative analysis using an Odyssey
Infrared Imager, respectively.
Protein Expression and Purification. GST-ICP27 and truncations
were expressed in 200-mL cultures of Escherichia coli BL21
(DE3) pLysS (Novagen) after a 4-h induction with 1 mM iso-
propyl-β-D-thiogalactopyranoside (IPTG) at 25 °C. Bacteria were
lysed in 10 mL of 50 mM Tris·HCl (pH 8), 100 mM NaCl, 1×
BugBuster (Novagen), 1,000 U/mL lysozyme (Novagen), and
25 U/mL Benzonase (Novagen), containing protease inhibitor
mixture (Roche). Cell debris was removed by centrifugation.
Lysates were incubated with preswollen glutathione 4B Sephar-
ose beads (Amersham Pharmacia) for 3 h at 4 °C with rotation
before washing four times in 5 mL of 50 mM Tris·HCl (pH 8),
150 mM NaCl, and 0.1% Nonidet P-40. Bound protein was
eluted in 50 mM Tris·HCl (pH 8), 150 mM NaCl, 1.5 mMMgCl2,
0.5 mM DTT, 20 mM reduced glutathione, and 20% glycerol,
and stored at −80 °C.
GST-PABP1 and truncations were expressed during a 3.5-h
induction with 1 mM IPTG at 30 °C. Bacteria were lysed in PBS
(pH 7.4) containing 1× BugBuster, 1 mM DTT, 5 mg/mL lyso-
zyme, 50 U/mL Benzonase, 500 U/mL RNase 1 (Ambion), and
protease inhibitor mixture (Roche). Cell debris was removed by
centrifugation, and lysates were incubated with preswollen gluta-
thione 4B Sepharose beads for 3 h at 4 °C with rotation before
washing five times in 5 mL of PBS and eluting in 50 mM Tris·HCl
(pH 8), 20 mM reduced glutathione, and 33% glycerol. Aliquots
were stored at −80 °C. Purified FLAG-eIF4G was a gift from
Simon Morley, University of Sussex, Brighton, UK.
His-ICP27 was expressed in a 500-mL culture during a 4-h
induction with 1 mM IPTG at 25 °C. Bacteria were lysed in 10 mL
of 50 mM Tris·HCl (pH 8), 100 mM NaCl, 0.5 mM DTT, 0.05%
Nonidet P-40, 1× BugBuster, 1,000 U/mL lysozyme, and 25 U/mL
Benzonase containing EDTA-free protease inhibitor mixture
(Roche). Cell debris was removed by centrifugation, and lysates
were incubated with 0.5 mL of nickel-nitrilotriacetic acid (Ni-
NTA) agarose (Qiagen) for 1 h at 4 °C with rotation. Beads
were washed six times in 10 mL of 50 mM Tris·HCl (pH 8),
200 mM NaCl, 20 mM imidazole, 0.5 mM DTT, and 0.05%
Nonidet P-40. Protein was eluted in 0.5-mL fractions in 50 mM
Tris·HCl (pH 8), 150 mM NaCl, 1.5 mM MgCl2, 0.5 mM DTT,
250 mM imidazole, and 20% glycerol, and stored at −80 °C.
His-PABP1 was expressed in a 200-mL culture during a 3.5-h
induction with 1 mM IPTG at 22 °C. Bacteria were lysed in 5 mL of
PABP lysis buffer [20 mM Tris·HCl (pH 8), 150 mM NaCl, 10 mM
imidazole, 1 mM DTT, 1× BugBuster, 1,000 U/mL lysozyme,
25 U/mL Benzonase] containing EDTA-free protease inhibitor
mixture (Roche). Cell debris was removed by centrifugation, and
lysates were incubated with 0.5 mL of Ni-NTA agarose for 2 h at
4 °C with rotation. Beads were washed once in PABP lysis buffer
and twice in 20 mM Tris·HCl (pH 8), 300 mM NaCl, 10 mM
imidazole, and 1 mMDTT. Protein was eluted in 0.5-mL fractions
in 20 mMTris·HCl (pH 8), 150 mMNaCl, 250 mM imidazole, and
1 mM DTT. Proteins were resolved by SDS/PAGE and visualized
with Gelcode Blue (Pierce).
GST Pull-Down Assay. Before pull-downs, purified proteins were
visualized by SDS/PAGE and SYPRORuby (Invitrogen) staining
and full-length proteins were quantified using a phosphoimager
with a BSA dilution series as standards. Three picomoles of GST/
GST-PABP1 or His-PABP1 and 15 pmol of His-ICP27 or GST/
GST-ICP27/GST-ICP27 truncations were incubated with 50 μL
of equilibrated glutathione Sepharose in 1.5 mL of binding
buffer [50 mM Tris·HCl (pH 8), 100 mM NaCl, 0.1% Nonidet
P-40, 500 U/mL RNase 1] for 3 h at 4 °C and washed six times in
50 mM Tris·HCl (pH 8), 200 mM NaCl, and 0.1% Nonidet P-40.
For the ternary complex, 15 pmol of GST/GST-ICP27, 15 pmol
of His-PABP1, and 10 pmol of FLAG-tagged eIF4G were in-
cubated with 30 μL of glutathione Sepharose for 3 h at 4 °C in
1.3 mL of 50 mM Tris·HCl (pH 8), 100 mM NaCl, 1.5 mM
MgCl2, and 0.05% Nonidet P-40 before washing three times in
the same buffer. For pull-downs with cell extracts, 5 μg of GST-
PABP1 (or truncations) was incubated for 3 h at 4 °C with 100 μg
of HSV-1–infected BHK cell extract and 50 μL of glutathione
Sepharose in 1 mL of binding buffer. Beads were washed five
times in 50 mM Tris·HCl (pH 8), 150 mM NaCl, and 0.1%
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Nonidet P-40. Protein was eluted in 20 μL of loading buffer for
5 min at 90 °C and analyzed by immunoblotting.
Y2H Analysis. Y2H analyses were performed with the MaV99 and
L40ura− yeast strains as described elsewhere (24). ICP27 lacks
the first nine amino acids, which cause trans-activation by
ICP27 alone (38).
Coimmunoprecipitations. One hundred micrograms of cell extract
was mixed with 100 ng of anti-ICP27 antibodies 1113 and 1119
(Virusys), 100 ng of mouse IgG (Sigma), or normal mouse serum
in 500 μL of buffer E [100 mM Tris·HCl (pH 7.4), 100 mM
NaC1, 1% Nonidet P-40, 0.5% Na deoxycholate] containing
protease inhibitor mixture (Roche) for 2 h at 4 °C with or
without 5 μg of RNase A (Ambion), 100 units of RNase 1
(Sigma), or 200 units of RNase T1 (Sigma) per 100 μg of total
protein. One hundred fifty microliters of protein A-Sepharose
was added and incubated for 3 h at 4 °C. Resin was washed six
times with buffer E and eluted in 50 μL of loading buffer [50 mM
Tris·HCl (pH 6.8), 100 mM DTT, 2% SDS, 0.1% bromophenol
blue, 10% glycerol]. Samples were analyzed by immunoblotting.
RNA coimmunoprecipitation was carried out from oocytes
microinjected with 50 ng of MS2 or MS2-ICP27 mRNA, in-
cubated for 6 h, microinjected with 25 pg of ApG-capped lucif-
erase reporter mRNA, and incubated for 3 h. Oocytes were
mechanically lysed in 10 μL per oocyte of 20 mMHepes (pH 7.6),
10 mM KCl, 1.5 mM MgCl2, 100 mM NaCl, 5 mM NaF, 1 mM
DTT, 800 U/mL RNasin (Promega), 0.5% Triton X-100, and
0.5% Na deoxycholate containing protease inhibitor mixture.
ePABP [the major PABP family member expressed in oocytes
(31)] was immunoprecipitated with 0.5 μg of anti-ePABP anti-
body per milligram of total protein or rabbit IgG as a control in
the presence of 50 μL of protein A-Sepharose for 2 h at 4 °C.
Beads were washed seven times in 20 mM Hepes (pH 7.6),
10 mM KCl, 1 mM MgCl2, 350 mM NaCl, and 0.05% Nonidet
P-40. Samples were evenly split for protein and RNA analysis.
Protein was analyzed as above. RNA was purified using Tri
Reagent (Sigma) and analyzed by 25-cycle amplification using
Titan One Tube RT-PCR (Roche) with primers 5′-GGCGC
GGTCG GTAAA GTT and 5′-AGCGT TTTCC CGGTA
TCCA (luciferase) or 5′-TGGTG ACAAT GCCAT GTTC and
5′-GATAA TGGAT CTGGT ATGTG (β-actin).
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Fig. S1. ICP27 associates with PABP in vivo, and PABP interacts directly with ICP27 in vitro. (A and B) PABP specifically coimmunoprecipitates with
ICP27 from HSV-1–infected BHK cell extracts, prepared 5 h postinfection. (A) HSV-1 (KOS 1.1)–infected cell extracts were incubated with normal mouse
serum (NMS) (lane 2) or anti-ICP27 monoclonal antibodies 1113 and 1119 (lanes 3–6) in the absence (lane 3) or presence of RNase A, 1, or T1 (lanes 4–6). IP,
immunoprecipitation. ICP27 (Upper) or PABP (Lower) was detected by immunoblotting. (Upper) Lower band in the upper panel is IgG heavy chain. (B) Wild
type (WT; KOS 1.1) HSV-1, ICP27-null (27lacZ ) HSV-1 (where the gene encoding ICP27 is replaced by lacZ ), or mock-infected (MI) BHK cell extracts were
incubated with a mixture of anti-ICP27 monoclonal antibodies 1113 and 1119 (lanes 1–4) or NMS (lane 5). ICP27 (Upper) and coimmunoprecipitated PABP
(Lower) were detected by immunoblotting. RNase A treatment is indicated by a + symbol. The lower protein band in each panel is the IgG heavy chain.
PABP is only coimmunoprecipitated from infected cells expressing ICP27. (C) ICP27 and PABP interact directly on a subset of HSV-1 transcripts. The mul-
tifunctional ICP27 protein (red) binds to most viral mRNAs, which are polyadenylated and may therefore also bind PABP (green). This property allows for
their fortuitous mRNA-mediated coisolation, which is RNase-sensitive. However, our data suggest that ICP27 stimulates the translation of a subset of
transcripts (e.g., VP16) by directly recruiting additional PABP to these mRNAs (Fig. 5A). Consequently, on these mRNAs, ICP27 and PABP are present in a
functional complex (mediated by protein–protein interactions) that is RNase-insensitive. (D–G) Expression and purification of recombinant proteins.
Recombinant proteins were expressed in and purified from E. coli BL21 (DE3) pLysS by affinity chromatography, resolved by SDS/PAGE, and visualized with
Gelcode Blue. Molecular masses (kilodaltons) are indicated. (D) GST and GST-PABP. Full-length His-ICP27 (E ) and GST-ICP27 (F ) are indicated. The lower
doublet in E and F was identified by immunoblotting as characteristic N-terminal ICP27 breakdown products. (G) His-PABP. (H) Immobilized purified GST-
ICP27 or GST was incubated with purified His-PABP. Coisolated PABP was detected by immunoblotting; input represents 150%.
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Fig. S2. Tether-function reporter mRNAs are stable in oocytes. (A) Diagram of reporter and internal control mRNAs used in the tether-function assays
throughout this report. ICP27 is expressed in X. laevis stage VI oocytes as a fusion with the phage MS2 coat protein (MS2) and tethered to luciferase mRNA via
the interaction of MS2 with three cognate-binding sites within the 3′ UTR (Luc-MS23). Reporter mRNAs are unadenylated, unless otherwise stated ([3], [4]), and
have a 5′ m7GpppG or ApppG cap (m7G-Luc-MS23 [1], [3] and ApG-Luc-MS23 [2], [4]) or an IRES as indicated (CSFV-Luc-MS23, PV-Luc-MS23, or HAV-Luc-MS23 [5])
in the main text. IRES-reporter constructs are ApppG-capped. A luciferase reporter mRNA lacking the MS2-binding sites is designated ApG-Luc-ΔMS2 [6]. An
m7GpppG-capped polyadenylated lacZ mRNA containing no MS2-binding sites is used as an internal control (β-gal [7]). For the modified tether-function assay
(Figs. 4C and 5B), an ApppG-capped, unadenylated, CSFV IRES-dependent internal control mRNA (CSFV–β-gal [8]) was used. (B and C) ICP27 alone is insufficient
to activate VP16 mRNA translation efficiently. (B) X. laevis oocytes were injected with 50 ng of mRNA expressing ICP27, and ICP27 protein was detected by
immunoblotting after overnight incubation. (C) In vitro-transcribed mRNA encoding VP16 (50, 250, or 500 pg) was injected into oocytes expressing either
ICP27 or U1A (negative control), and VP16 protein was detected by immunoblotting after overnight incubation. (D) ICP27 does not affect reporter mRNA
levels, consistent with the remarkable stability of mRNAs in oocytes (18). Oocytes expressing MS2 or MS2-ICP27 were injected with ApG-Luc-MS23, PV-Luc-MS23,
HAV-Luc-MS23, or CSFV-Luc-MS23 reporter mRNAs. Total RNA was extracted either immediately (0h) or 14 h (14h) after injection and analyzed by quantitative
RT-PCR with primers against the luciferase ORF, showing equivalent levels of mRNA. The number of amplification cycles required to obtain a detectable
product in the linear range (threshold cycle) is shown. Error bars represent SEM.
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Fig. S3. ICP27 requires PABP binding to activate translation. (A) ICP27 deletion and point mutations used in this study. (Upper) Full-length ICP27 consists of
512 amino acids. RGG-box, RNA-binding domain; Zn, C-terminal zinc finger region. (Lower) Horizontal bars and gaps indicate amino acids present and absent,
respectively. Vertical bars in M15 and M16 indicate the positions of point mutations. (B) Purification of GST fusions of ICP27 truncations. Recombinant proteins
were expressed from the plasmids described in Table S2 and purified from E. coli BL21 (DE3) pLysS by affinity chromatography, resolved by SDS/PAGE, and
visualized with Gelcode Blue. Molecular masses (kilodaltons) are indicated. (C) PABP contains four functionally nonequivalent RRM domains and a C-terminal
region composed of a proline-rich linker (line) and the PABC domain. Minimal mapped binding regions for translation initiation factors are indicated (ref. 20
and references therein). Interaction with eIF4B requires integrity of the PABP C-terminal region (dotted line). (D) GST fusions of different PABP domains
purified from the plasmids listed in Table S2 as described in Fig. S1. (E) PABP coimmunoprecipitates with WT, but not M15/M16 mutant ICP27 from HSV-1–
infected cell extracts. HSV-1–infected cell extracts were incubated anti-ICP27 monoclonal antibodies 1113 and 1119. ICP27 expression (Upper) and coimmu-
noprecipitated PABP (Lower) were detected by immunoblotting. The dashed vertical line indicates removal of irrelevant lanes from the gel.
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Fig. S4. ICP27-mediated translational activation is sensitive to reporter mRNA poly(A) tail length in a tether-function assay. (A) Oocytes expressing MS2 or
MS2-ICP27 were coinjected with β-gal mRNA and m7G-Luc-MS23 or an identical reporter mRNA with a 3′ poly(A) tail (m7G-Luc-MS23-pA) (Fig. S2A, [7], [1], and
[3], respectively). (Upper) Luciferase activity normalized to β-gal activity is plotted. (Lower) Relative stimulation compared with MS2 (set to 1) is plotted. (Upper)
Polyadenylated reporter mRNA is translated more efficiently than its unadenylated counterpart, and translation of both reporters is stimulated by tethered
ICP27. (Lower) Importantly, the relative increase in translational efficiency by ICP27 is greater with the unadenylated reporter than with the polyadenylated
reporter. This result is consistent with ICP27 acting via recruitment of PABP, because this mode of action should result in a less pronounced stimulatory effect of
MS2-ICP27 on polyadenylated reporter mRNAs, which will be bound by additional PABP molecules, compared with unadenylated reporter mRNAs, which can
only recruit PABP via ICP27. (B) As in A, but substituting ApppG-capped for m7GpppG-capped reporter mRNAs (ApG-Luc-MS23 and ApG-Luc-MS23-pA; Fig. S2A,
[2] and [4], respectively) and with the inclusion of MS2-PABP. The use of ApppG-capped reporters [with or without a poly(A) tail], which are translated at a
substantially reduced rate (Fig. S5A), excludes the possibility that the reduced relative stimulation by ICP27 observed in A is a consequence of a maximal
translation level being reached. A similar result was observed when PABP was directly tethered. Taken together, these results provide strong support for a
mechanism whereby ICP27 functions by facilitating the recruitment of PABP. Error bars denote SEM from three repeats.
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Fig. S5. (A) Translation in X. laevis oocytes is highly sensitive to the presence of a functional cap, and the HAV IRES is active in X. laevis oocytes. Oocytes were
coinjected with 375 pg of β-gal internal control mRNA and 750 pg of of m7G-Luc-MS23, ApG-Luc-MS23 (Fig. S2A, [1] and [2]), m7GpppG-capped HAV-Luc-MS23,
or ApppG-capped HAV-Luc-MS23 mRNAs. The former two mRNAs show that replacing the physiological m
7GpppG cap with ApppG results in a >70-fold re-
duction of translational efficiency. The latter two mRNAs contain the HAV IRES, although one is physiologically capped (m7GpppG) and the other is not
(ApppG). The presence of the HAV IRES promotes efficient translation of the ApppG-capped mRNA (compare ApG-HAV-Luc-MS23 versus ApG-Luc-MS23 and
m7G-Luc-MS23), showing that it is functional in oocytes. Luciferase activity normalized to β-gal activity is plotted. Error bars indicate SEM. (B) ICP27 activates a
nonphysiologically (ApppG)-capped reporter mRNA in a tether-function assay. Oocytes expressing MS2 or MS2-ICP27 were coinjected with β-gal mRNA and
m7G-Luc-MS23 or ApG-Luc-MS23 (Fig. S2A, [1], [2] and [7]). Effects on translation were measured by luciferase assay normalized for β-gal activity. Translational
stimulation relative to MS2 protein alone (set to 1) is plotted. Error bars indicate SEM from three repeats. (C) Translational activation of different reporter
mRNAs by tethered full-length PABP recapitulates translational stimulation by tethered ICP27. Oocytes expressing MS2, MS2-ICP27, or MS2-PABP were
coinjected with β-gal mRNA and m7G-Luc-MS23 or CSFV-Luc-MS23 mRNA, HAV-Luc-MS23 mRNA, PV-Luc-MS23 mRNA, or ApG-Luc-MS23 mRNA (Fig. S2A, [7], [1],
[5], and [2], respectively). Effects on translation were measured by luciferase assay normalized for minor changes in β-gal activity. Translational stimulation
relative to translational stimulation of MS2 is plotted; error bars indicate SEM.
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Fig. S6. (A) Purified eIF4G. FLAG fusion of eIF4G (amino acids 1–532) visualized with Gelcode Blue. (B) 2A protease does not disrupt CSFV IRES-dependent
translation initiation. Oocytes were injected with m7G-Luc-MS23 (Left) or CSFV–β-gal (Right) mRNAs (Fig. S2A, [3] and [8]) and increasing amounts of mRNA
expressing 2Apro. Luciferase and β-gal activities were determined, showing that 2Apro inhibits cap-dependent (Left) but not eIF4G-independent (Right) CSFV
IRES-driven translation, as expected. (C) Oocytes were uninjected (−) or injected with mRNA expressing 2Apro or U1A (a proteolytically and translationally inert
control protein). After 3 h, extracts were prepared and endogenous eIF4G, PABP, and Paip1 were analyzed by immunoblotting. (D) Dazl activates a non-
physiologically (ApppG)-capped reporter mRNA in a tether-function assay. Oocytes expressing MS2-U1A or MS2-Dazl were coinjected with β-gal mRNA and
m7G-Luc-MS23 or ApG-Luc-MS23 (Fig. S2A, [1], [2], and [7]). Effects on translation were measured by luciferase assay normalized for β-gal activity. Translational
stimulation relative to MS2-U1A (set to 1) is plotted. Error bars indicate SEM from six repeats.
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Table S1. Y2H analysis of the interaction of ICP27 and
translation initiation factors
Binding domain Activation domain Interaction*
Lex A ICP27 −
eIF4G Ct ICP27 −
PABP Ct ICP27 ++++
ICP27 IRP −
ICP27 PABP Ct +++
ICP27 eIF1 −
ICP27 eIF1A −
ICP27 eIF2α +/−
ICP27 eIF2β +/−
ICP27 eIF3 S1 −
ICP27 eIF3 S2 +/−
ICP27 eIF3 S3 −
ICP27 eIF3 S4 +
ICP27 eIF3 S5 +/−
ICP27 eIF3 S6 +/−
ICP27 eIF3 S7 +/−
ICP27 eIF3 S8 −
ICP27 eIF4A +/−
ICP27 eIF4B −
ICP27 eIF4E +/−
ICP27 eIF4G Nt −
ICP27 eIF4H −
ICP27 eIF5 −
ICP27 eIF5A −
ICP27 eIF5B −
ICP27 Paip 1 −
Ct, C terminus; Nt, N terminus.
*Y2H interactions were determined with a β-gal filter assay as described (24).
Color development is denoted by a + symbol, with multiple + symbols rep-
resenting increasing intensity relative to the negative control. The symbol
+/− represents faint color development in some colonies.
Table S2. GST-PABP1 and GST-ICP27 expression plasmids used in this study
Plasmid GST fusion Source
pGEX-2T-PABP1 GST-PABP1 full length (39)
pGEX6P-PABP1-RRM1-HA GST-PABP1 (amino acids 1–98) (40)
pGEX6P-PABP1-RRM2-HA GST-PABP1 (amino acids 99–190) (40)
pGEX6P-PABP1-RRM3-HA GST-PABP1 (amino acids 191–289) (40)
pGEX6P-PABP1-RRM4-HA GST-PABP1 (amino acids 290–368) (40)
pGEX6P-PABP1-RRM1+2-HA GST-PABP1 (amino acids 1–190) (40)
pGEX6P-PABP1-RRM2+3-HA GST-PABP1 (amino acids 98–289) (40)
pGEX6P-PABP1-RRM3+4-HA GST-PABP1 (amino acids 191–368) (40)
pGEX6P-PABP1-C1-HA GST-PABP1 (amino acids 369–494) (40)
pGEX6P-PABP1-C2-HA GST-PABP1 (amino acids 495–633) (40)
pPABP1-C5 GST-PABP1 (amino acids 462–634) (41)
pGST-PABP1-CTD GST-PABP1 (amino acids 388-636) This work
pGEX-27 GST-ICP27 full-length (36)
pGST-1–261 GST-ICP27 (amino acids 1–261) This work
pGST-12–397 GST-ICP27 (amino acids 12–397) This work
pGST-12–512 GST-ICP27 (amino acids 12–512) This work
pGST-72–512 GST-ICP27 (amino acids 72–512) This work
CTD, C-terminal domain.
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